Mansarover Inc

Tackling aging with multiomics drug discovery 

For investors 

About us

Aging is the biggest risk-factor for cancers, heart disease, Alzheimer’s, and other detrimental indications. We’re on a mission to therapeutically reverse aging to prevent and treat these diseases.

We tackle the complexity of aging with deep-learning-guided, multiomics drug design that optimizes  thousands of drug interactions implicated in longevity, safety, and systemic deliverability


Vetted in dozens of publications

Our drug discovery and design platform, CANDO, is a robust IP-generating engine benchmarked and validated in hundreds of applications across dozens of indications. With Mansarover, we're excited to utilize its multiomics scale to design new rejuvenating therapies for longevity and age-related diseases. Read a few selected publications on our platform here:


Brennan Overhoff

Entrepreneurial lead and primary platform/ML developer. 5+ years experience in fullstack development. 2+ year research fellow at the Division of Bioinformatics, University at Buffalo. Currently studying Regenerative Biology and Physics at Harvard University; student member at Harvard Innovation Labs.

William Mangione

Primary platform developer leading network/omics integration. Received PhD in Biomedical Informatics from the University at Buffalo. 6+ years of research in computational drug discovery.

Zackary Falls

Primary platform developer. Received PhD in Computational Chemistry from the University at Buffalo. 5+ years of research in computational drug discovery. 

Ram Samudrala

Professor and Division Chief of Bioinformatics at the University at Buffalo. Led 20+ year research program in structural biology and computational drug discovery with multiple therapeutics patents. Received PhD from the University of Maryland followed by a Postdoctoral Fellowship at Stanford University.


As a drug discovery company, we're always looking for new and exciting partnership opportunities with companies in longevity biotech. Don't hesitate to reach out if your company is working on complex mechanisms of aging, multiple difficult targets,  or transcription factors/biologics therapies in need of improved deliverability.

Contact us



@ Harvard Innovation Labs

Batten Hall, 125 Western Ave
Allston, MA 02134